Fresenius Medical Care AG (FMS) Depreciation & Amortization (CF) (2009 - 2025)

Fresenius Medical Care AG's Depreciation & Amortization (CF) history runs 10 years deep, the most recent figure standing at $434.2 million for Q4 2025.

• In Q4 2025, Depreciation & Amortization (CF) fell 14.82% year-over-year to $434.2 million; the TTM figure through Dec 2025 stood at $1.7 billion (down 10.12% YoY), while the FY2025 annual figure was $1.7 billion, down 6.25% from the prior year.
• Depreciation & Amortization (CF) was $434.2 million for Q4 2025 at Fresenius Medical Care AG, up from $418.4 million in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $556.2 million in Q1 2024 to a low of $400.9 million in Q3 2024.
• Historically, Depreciation & Amortization (CF) has averaged $466.1 million across 5 years, with a median of $470.1 million in 2022.
• The sharpest annual moves came in 2021 and 2024: Depreciation & Amortization (CF) fell 27.83% in 2021, then grew 18.36% in 2024.
• A 5-year view of Depreciation & Amortization (CF) shows it stood at $499.9 million in 2021, then climbed by 1.02% to $505.0 million in 2022, then slipped by 9.24% to $458.4 million in 2023, then gained by 11.21% to $509.7 million in 2024, then decreased by 14.82% to $434.2 million in 2025.
• The last three Depreciation & Amortization (CF) figures came in at $434.2 million (Q4 2025), $418.4 million (Q3 2025), and $425.6 million (Q2 2025), per Business Quant data.